We value strong partnerships and their power to transform current practices in healthcare.
Organisations and Institutes
Join us for better health. Empower people.
By partnering with other key organizations, we can make a more significant impact in hopes for over 350 million families to experience the fullness of life. Together with our partners, we have created a new way to approach diagnosis and treatment of genetic disorders that promotes health and social equality, improves quality of life and supports care teams.
We work together with leading universities, institutes and advocacy groups in Denmark and abroad, to ensure effective use of breakthrough technologies and intelligence and fair access for all.
Every investment in gMendel® can shape a new future for genetic disorders.
gMendel® capitalizes on superior proprietary technology and expertise to democratize genetic diagnosis. We are building a better future for health care by enabling early, accurate and affordable diagnosis of genetic disorders. Our approach enables targeted treatment strategies, efficient disease management and sustainable health economics for national health systems.
For us, scientific progress and responsible entrepreneurship go hand in hand. We aspire to create value and growth for people and the society at large in every level of our business. Through transparency and accuracy, we envisage to deliver significant financial benefits, achieve financial flexibility and build a loyal shareholder base.